Robert Solinga

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

Robert Busby, Alexander P. Bryant, Wilmin Bartolini et al. · European Journal of Pharmacology · 2010 · 245 citations

Signal Transduction, Biochemistry, Enhanced Intestinal Secretion +9

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

Alexander P. Bryant, Robert Busby, Wilmin Bartolini et al. · Life Sciences · 2010 · 221 citations

Molecular Pharmacology, Biochemistry, Gastrointestinal Pharmacology +8

Immunization with <i>Staphylococcus aureus</i> Clumping Factor B, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model

Adam C. Schaffer, Robert Solinga, Jordan L. Cocchiaro et al. · Infection and Immunity · 2006 · 168 citations · Full text

Humoral Response, Immunology, Staphylococcus Aureus +20

Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Robert Busby, Marco M. Kessler, Wilmin Bartolini et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 132 citations

CD4 ⁺ T cells and CXC chemokines modulate the pathogenesis of <i>Staphylococcus aureus</i> wound infections

Rachel M. McLoughlin, Robert Solinga, Jeremy Rich et al. · Proceedings of the National Academy of Sciences · 2006 · 115 citations · Full text